☆ 4.5 Article

Transplacental transfer of SARS-CoV-2 antibodies: a cohort study

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2023)

Related references

Note: Only part of the references are listed.

Article Medical Laboratory Technology

Placental Tissue Destruction and Insufficiency From COVID-19 Causes Stillbirth and Neonatal Death From Hypoxic-Ischemic Injury

David A. Schwartz et al.

Summary: This study evaluated the mechanism of stillbirth and neonatal death following maternal infection with COVID-19. The findings suggest that placental abnormalities caused by SARS-CoV-2 infection result in placental malperfusion and insufficiency, leading to fetal hypoxic-ischemic injury and perinatal death.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2022)

Add to Collection

Article Infectious Diseases

Timing of SARS-CoV-2 vaccination during the third trimester of pregnancy and transplacental antibody transfer: a prospective cohort study

Amihai Rottenstreich et al.

Summary: This study aimed to evaluate the impact of maternal vaccination against SARS-CoV-2 in early versus late third trimester on transplacental transfer and neonatal levels of antibodies. The results showed that early vaccination in pregnancy enhanced transplacental antibody transfer and increased neonatal neutralizing antibody levels, indicating that early vaccination in the third trimester may enhance neonatal immune protection.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

Add to Collection

Article Pathology

Severe placental lesions due to maternal SARS-CoV-2 infection associated to intrauterine fetal death

Charlotte Dubucs et al.

Summary: SARS-CoV-2 infection can cause severe placental lesions leading to intrauterine fetal death. These lesions are independent of the severity of maternal COVID-19 symptoms and are difficult to predict. In some cases, the placental lesions have a focal distribution and do not result in fetal death, but may lead to intrauterine growth restriction. Therefore, future pregnancy guidance may need to include enhanced screening and monitoring measures for COVID-19.

HUMAN PATHOLOGY (2022)

Add to Collection

Article Pediatrics

Maternal and Neonatal SARS-CoV-2 Immunoglobulin G Antibody Levels at Delivery After Receipt of the BNT162b2 Messenger RNA COVID-19 Vaccine During the Second Trimester of Pregnancy

Nir Kugelman et al.

Summary: Vaccination with the BNT162b2 mRNA COVID-19 vaccine during the second trimester of pregnancy was associated with strong maternal and neonatal humoral responses, reflected in IgG antibody levels. This supports the vaccination of pregnant individuals in the second trimester for maternal protection and newborn safety during the pandemic.

JAMA PEDIATRICS (2022)

Add to Collection

Article Health Care Sciences & Services

COVID-19 mRNA vaccine in pregnancy: Results of the Swiss COVI-PREG registry, an observational prospective cohort study

Guillaume Favre et al.

Summary: Safety of mRNA COVID-19 vaccines in pregnancy was assessed in this study. The results showed that although common local and systemic reactions were reported during vaccine administration, severe events were rare. Women vaccinated during pregnancy did not experience higher adverse pregnancy or neonatal outcomes compared to historical data on background risks in the obstetric population.

LANCET REGIONAL HEALTH-EUROPE (2022)

Add to Collection

Article Medical Informatics

The effect of maternal SARS-CoV-2 infection timing on birth outcomes: a retrospective multicentre cohort study

Samantha N. Piekos et al.

Summary: The study evaluated the impact of maternal SARS-CoV-2 infection on birth outcomes and developed models to predict gestational age at delivery following an infection during pregnancy. Results showed an increased risk of preterm delivery and stillbirth, primarily associated with first and second trimester infections. Monitoring and prenatal care are recommended for pregnant individuals after SARS-CoV-2 infection in early pregnancy, regardless of COVID-19 severity.

LANCET DIGITAL HEALTH (2022)

Add to Collection

Article Obstetrics & Gynecology

Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies among parturient women treated with BNT162b2 messenger RNA vaccine during pregnancy

Omer Nir et al.

Summary: This study found that SARS-CoV-2 immunoglobulin G can efficiently transfer across the placenta from pregnant women vaccinated with the BNT162b2 mRNA vaccine to their neonates. There was a positive correlation between antibody concentrations in maternal and cord blood, indicating potential neonatal humoral immunity provided by maternal vaccination.

AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM (2022)

Add to Collection

Article Obstetrics & Gynecology

Severe acute respiratory syndrome coronavirus 2 serology levels in pregnant women and their neonates

Jeffrey M. Kubiak et al.

Summary: This study examined the serologic response in pregnant women to SARS-CoV-2 and explored its correlation with maternal clinical presentation as well as the passive immunity received by neonates. The results showed that maternal serologies were correlated with symptomatic maternal infection, and higher levels of maternal antibodies were associated with passive neonatal immunity.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Compromised SARS-CoV-2-specific placental antibody transfer

Caroline Atyeo et al.

Summary: SARS-CoV-2 infection causes more severe disease in pregnant women compared to age-matched non-pregnant women. Transfer of SARS-CoV-2-specific antibodies across the placenta is significantly reduced compared to other infectious diseases like influenza and pertussis, but can be partially rescued by infection-induced increases in IgG and increased FCGR3A placental expression. These findings provide insights for maternal vaccine design to boost immunity in neonates.

CELL (2021)

Add to Collection

Article Infectious Diseases

False-positive results of SARS-CoV-2 IgM/IgG antibody tests in sera stored before the 2020 pandemic in Italy

Anna Latiano et al.

Summary: The study evaluated the performance of serological tests using serum samples collected before the outbreak of COVID-19 in 2018 and 2019, highlighting the limited usefulness of serological testing for detecting SARS-CoV-2 virus based on pre-outbreak specimens.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Microbiology

Comparison of 16 Serological SARS-CoV-2 Immunoassays in 16 Clinical Laboratories

Lene H. Harritshoj et al.

Summary: This study evaluated the diagnostic accuracy of 15 commercial and one in-house anti-SARS-CoV-2 assays in Danish laboratories. Most total antibody and IgG assays showed high sensitivity and specificity, with some overlap in confidence intervals. IgM results were more variable, with one assay demonstrating higher sensitivity and specificity.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)

Add to Collection

Article Pediatrics

Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios

Dustin D. Flannery et al.

Summary: Efficient transplacental transfer of SARS-CoV-2 IgG antibodies supports the potential for maternally derived antibodies to provide neonatal protection from SARS-CoV-2 infection. This cohort study assesses the association between maternal and neonatal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibody concentrations.

JAMA PEDIATRICS (2021)

Add to Collection

Article Obstetrics & Gynecology

SARS-CoV-2 infection in pregnancy in Denmark-characteristics and outcomes after confirmed infection in pregnancy: A nationwide, prospective, population-based cohort study

Anna J. M. Aabakke et al.

Summary: Among pregnant women infected with SARS-CoV-2, only 5.5% required hospital admission due to COVID-19 symptoms. Risk factors for admission included obesity, smoking, asthma, and infection after gestational age 22 weeks. Severe adverse outcomes of SARS-CoV-2 infection in pregnancy were rare.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy

Noa Dagan et al.

Summary: The BNT162b2 COVID-19 vaccine showed high effectiveness in pregnant women in an observational cohort study in Israel, similar to the effectiveness seen in the general population.

NATURE MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study

Dongli Song et al.

Summary: Maternal SARS-CoV-2 IgG can efficiently transfer across the placenta when infections occur more than 2 months before delivery, and maternal passive immunity may persist in infants up to 6 months of life. The antibody levels in infants correlate with those in the cord blood during the first 28 weeks after birth.

BMJ OPEN (2021)

Add to Collection

Correction Medicine, Research & Experimental

Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine (vol 131, e150319, 2021)

Ofer Beharier et al.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection

Article Obstetrics & Gynecology

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies at Delivery in Women, Partners, and Newborns

Pia Egerup et al.

Summary: This study investigated the frequency of SARS-CoV-2 antibodies in parturient women, their partners, and newborns, and the association with obstetric and neonatal outcomes. No association was found between SARS-CoV-2 infection and obstetric or neonatal complications, but some newborns born to mothers with antibodies had SARS-CoV-2 IgG antibodies at birth. The study was limited by a lack of statistical power to detect small but potentially meaningful differences between those with and without evidence of infection.

OBSTETRICS AND GYNECOLOGY (2021)

Add to Collection

Article Infectious Diseases

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Victor M. Corman et al.

EUROSURVEILLANCE (2020)

Add to Collection

Article Virology

Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays

Lisa Weidner et al.

JOURNAL OF CLINICAL VIROLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic

Andrea G. Edlow et al.

JAMA NETWORK OPEN (2020)

Add to Collection

Article Infectious Diseases

Perinatal analyses of Zika- and dengue virus-specific neutralizing antibodies: A microcephaly case-control study in an area of high dengue endemicity in Brazil

Priscila M. S. Castanha et al.

PLOS NEGLECTED TROPICAL DISEASES (2019)

Add to Collection

Review Immunology

Transfer of maternal immunity and programming of the newborn immune system

Madeleine F. Jennewein et al.

SEMINARS IN IMMUNOPATHOLOGY (2017)

Add to Collection

Article Medicine, General & Internal

Safety and Immunogenicity of Tetanus Diphtheria and Acellular Pertussis (Tdap) Immunization During Pregnancy in Mothers and Infants A Randomized Clinical Trial

Flor M. Munoz et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)

Add to Collection

Review Immunology

IgG Placental Transfer in Healthy and Pathological Pregnancies

Patricia Palmeira et al.

CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)

Add to Collection

Article Immunology

MATERNALLY DERIVED ANTIBODIES AGAINST BORDETELLA PERTUSSIS ANTIGENS PERTUSSIS TOXIN AND FILAMENTOUS HEMAGGLUTININ IN PRETERM AND FULL TERM NEWBORNS

Ulrich Heininger et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)

Add to Collection

Article Infectious Diseases

Dengue infection during pregnancy and transplacental antibody transfer in Thai mothers

C Perret et al.

JOURNAL OF INFECTION (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.